Literature DB >> 35577593

Steen solution protects pulmonary microvascular endothelial cells and preserves endothelial barrier after lipopolysaccharide-induced injury.

Huy Q Ta1, Nicholas R Teman1, Irving L Kron1, Mark E Roeser1, Victor E Laubach2.   

Abstract

OBJECTIVES: Acute respiratory distress syndrome represents the devastating result of acute lung injury, with high mortality. Limited methods are available for rehabilitation of lungs affected by acute respiratory distress syndrome. Our laboratory has demonstrated rehabilitation of sepsis-injured lungs via normothermic ex vivo and in vivo perfusion with Steen solution (Steen). However, mechanisms responsible for the protective effects of Steen remain unclear. This study tests the hypothesis that Steen directly attenuates pulmonary endothelial barrier dysfunction and inflammation induced by lipopolysaccharide.
METHODS: Primary pulmonary microvascular endothelial cells were exposed to lipopolysaccharide for 4 hours and then recovered for 8 hours in complete media (Media), Steen, or Steen followed by complete media (Steen/Media). Oxidative stress, chemokines, permeability, interendothelial junction proteins, and toll-like receptor 4-mediated pathways were assessed in pulmonary microvascular endothelial cells using standard methods.
RESULTS: Lipopolysaccharide treatment of pulmonary microvascular endothelial cells and recovery in Media significantly induced reactive oxygen species, lipid peroxidation, expression of chemokines (eg, chemokine [C-X-C motif] ligand 1 and C-C motif chemokine ligand 2) and cell adhesion molecules (P-selectin, E-selectin, and vascular cell adhesion molecule 1), permeability, neutrophil transmigration, p38 mitogen-activated protein kinase and nuclear factor kappa B signaling, and decreased expression of tight and adherens junction proteins (zonula occludens-1, zonula occludens-2, and vascular endothelial-cadherin). All of these inflammatory pathways were significantly attenuated after recovery of pulmonary microvascular endothelial cells in Steen or Steen/Media.
CONCLUSIONS: Steen solution preserves pulmonary endothelial barrier function after lipopolysaccharide exposure by promoting an anti-inflammatory environment via attenuation of oxidative stress, toll-like receptor 4-mediated signaling, and conservation of interendothelial junctions. These protective mechanisms offer insight into the advancement of methods for in vivo lung perfusion with Steen for the treatment of severe acute respiratory distress syndrome.
Copyright © 2022 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Steen solution; acute respiratory distress syndrome; endothelial barrier dysfunction; in vivo lung perfusion

Year:  2022        PMID: 35577593      PMCID: PMC9576825          DOI: 10.1016/j.jtcvs.2022.04.005

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   6.439


  36 in total

Review 1.  Multifunctional strands in tight junctions.

Authors:  S Tsukita; M Furuse; M Itoh
Journal:  Nat Rev Mol Cell Biol       Date:  2001-04       Impact factor: 94.444

Review 2.  Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets.

Authors:  Maria Giovanna Scioli; Gabriele Storti; Federico D'Amico; Roger Rodríguez Guzmán; Federica Centofanti; Elena Doldo; Ela María Céspedes Miranda; Augusto Orlandi
Journal:  J Clin Med       Date:  2020-06-25       Impact factor: 4.241

3.  Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration.

Authors:  Bastien Hermant; Stephanie Bibert; Evelyne Concord; Bernard Dublet; Marianne Weidenhaupt; Thierry Vernet; Danielle Gulino-Debrac
Journal:  J Biol Chem       Date:  2003-02-12       Impact factor: 5.157

4.  Bacterial lipopolysaccharide and tumor necrosis factor alpha synergistically increase expression of human endothelial adhesion molecules through activation of NF-kappaB and p38 mitogen-activated protein kinase signaling pathways.

Authors:  H P Jersmann; C S Hii; J V Ferrante; A Ferrante
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

5.  Heterogeneity of claudin expression by alveolar epithelial cells.

Authors:  Fushan Wang; Brandy Daugherty; Lisa L Keise; Zhangyong Wei; Joseph P Foley; Rashmin C Savani; Michael Koval
Journal:  Am J Respir Cell Mol Biol       Date:  2003-01-23       Impact factor: 6.914

6.  Ex Vivo Lung Perfusion Rehabilitates Sepsis-Induced Lung Injury.

Authors:  J Hunter Mehaffey; Eric J Charles; Ashish K Sharma; Morgan Salmon; Dustin Money; Sarah Schubert; Mark H Stoler; Curtis G Tribble; Victor E Laubach; Mark E Roeser; Irving L Kron
Journal:  Ann Thorac Surg       Date:  2017-04-21       Impact factor: 4.330

7.  p38 MAP kinase-dependent regulation of endothelial cell permeability.

Authors:  Talaibek Borbiev; Anna Birukova; Feng Liu; Saule Nurmukhambetova; William T Gerthoffer; Joe G N Garcia; Alexander D Verin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-11       Impact factor: 5.464

8.  TLR4 signaling is coupled to SRC family kinase activation, tyrosine phosphorylation of zonula adherens proteins, and opening of the paracellular pathway in human lung microvascular endothelia.

Authors:  Ping Gong; Daniel J Angelini; Shiqi Yang; Guanjun Xia; Alan S Cross; Dean Mann; Douglas D Bannerman; Stefanie N Vogel; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2008-03-07       Impact factor: 5.157

9.  Acute Respiratory Distress Syndrome.

Authors:  B Taylor Thompson; Rachel C Chambers; Kathleen D Liu
Journal:  N Engl J Med       Date:  2017-11-09       Impact factor: 91.245

10.  New insights into the steen solution properties: breakthrough in antioxidant effects via NOX2 downregulation.

Authors:  Roberto Carnevale; Giuseppe Biondi-Zoccai; Mariangela Peruzzi; Elena De Falco; Isotta Chimenti; Federico Venuta; Marco Anile; Daniele Diso; Elena Cavarretta; Antonino G M Marullo; Patrizio Sartini; Pasquale Pignatelli; Francesco Violi; Giacomo Frati
Journal:  Oxid Med Cell Longev       Date:  2014-04-16       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.